|
JYpartners |
[[¾à»ç, ÇѾà»ç Çʼö]] CRA 2³â ÀÌ»ó °æ·ÂÀÚ OK
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
2³â¡è |
ä¿ë½Ã |
05.06 |
|
|
ÄÉÀ̸ÇÆÄ¿ö |
[»óÀå Á¦¾à»ç] RA(Regulatory Affairs) ¹× ´ë°ü °ü¸®ÀÚ Ãʺù
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
10³â¡è |
ä¿ë½Ã |
03.01 |
|
|
(ÁÖ)ÇÇÇÃÄɾî½áÄ¡ |
Ç°Áú°ü¸® ¾à»ç QA - ÃÖ°í ´ë±â¾÷
´ëÀü ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
5³â¡è |
ä¿ë½Ã |
08.26 |
|
|
JYpartners |
[¿Ü±¹°è(µ¶ÀÏ)] Á¦¾àȸ»ç PM¸ðÁý
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
03.11 |
|
|
¾Æµ¥ÄÚÄÚ¸®¾Æ |
[±Û·Î¹ú ¿Ü±¹°è]ÀǾàÇ° ¹°·ù±â¾÷ °ü¸®¾à»ç
°æ±â ÀÌõ½Ã | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
3³â¡è |
ä¿ë½Ã |
05.14 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
»ç¾÷°³¹ß½ÇÆÀÀå(Business Development Team Leader)/±¹³»À¯
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
¾à»ç/ÇѾà»ç |
7³â¡è |
ä¿ë½Ã |
09.13 |
|
|
ÁÖ½Äȸ»ç ºñƼ¾Ø¾¾ |
oncology ÀǾàÇ° medical advisorä¿ë(¿Ü±¹°è Á¦¾à ±â¾÷)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
˂ȍ |
°æ·Â¹«°ü |
ä¿ë½Ã |
02.14 |
|
|
³×¸ðÆÄÆ®³ÊÁîHRG |
¿Ü±¹°è Á¦¾àȸ»ç Medical advisor (ÀÌ»ç±Þ)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
5³â¡è |
ä¿ë½Ã |
10.29 |
|
|
(ÁÖ)ÇÁ¶óÀ̸Ӹ®¿¡ÀÌÄ¡¾Ë |
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
3³â¡è |
ä¿ë½Ã |
08.26 |
|
|
¿¡´Ï±×¸¶ÄÁ¼³ÆÃ(ÁÖ) |
¿Ü±¹°è Á¦¾à»ç-MSL
¼¿ï °³²±¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
˂ȍ |
1³â¡è |
ä¿ë½Ã |
02.12 |
|
|
HRKorea |
¼öÀÇ»ç
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¼öÀÇ»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
07.06 |
|
|
HRKorea |
»ý»ê°ü¸®ºÎ (Á¦Á¶°ü¸®¾à»ç)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
01.04 |
|
|
JYpartners |
[[µ¶ÀÏ°è Åõ¼® Àü¹®±â¾÷]]PV manager ½Å±Ôä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
2³â¡è |
ä¿ë½Ã |
12.03 |
|
|
¼¿ï¿Ü´ë½ºÄ«¿ìÆ® |
(¿Ü±¹°ÔÁ¦¾à»ç)PV 0-3°æ·Â
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
1³â¡è |
ä¿ë½Ã |
03.11 |
|
|
JYpartners |
[[µ¶ÀÏ°è Åõ¼® Àü¹®±â¾÷]]PV manager ½Å±Ôä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
3³â¡è |
ä¿ë½Ã |
11.02 |
|